RAPT Therapeutics Inc
RAPT
Market Cap$99.47M
Close$
$1.06
40.5% upside
Current Fair Value
40.5% upsideUndervalued by 40.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $99.47 Million |
|---|---|
| Enterprise Value | $-65,775,725.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.19 |
| Beta | -0.04 |
| Outstanding Shares | 46,687,525 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.27 |
|---|---|
| PEG | 0.66 |
| Price to Sales | - |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | -12.44 |
| Enterprise Value to EBIT | 0.57 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.07 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About RAPT Therapeutics Inc
CEO: Brian Wong